P-glycoprotein and multidrug resistance-associated protein, but not lung resistance protein, lower the intracellular daunorubicin accumulation in acute myeloid leukaemic cells

British Journal of Haematology

Volumn 108, Issue 1, 2000, Pages 48-54

  Borg, Anton G ^a,b   Burgess, Robert ^a   Green, Linda M ^b   Scheper, Rik J ^c   Liu Yin, John A ^b  

^a University Department of Haematology   (United Kingdom)

^b MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Acute myeloid leukaemia; Daunorubicin; Multidrug resistance proteins

Indexed keywords

DAUNORUBICIN; GLYCOPROTEIN P; LUNG RESISTANCE PROTEIN; MULTIDRUG RESISTANCE PROTEIN;

ACUTE GRANULOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG TRANSPORT; FEMALE; HUMAN; HUMAN CELL; LEUKEMIA CELL; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION;

ACUTE DISEASE; ADOLESCENT; ADULT; AGED; ANTIBIOTICS, ANTINEOPLASTIC; DAUNORUBICIN; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; FEMALE; FLOW CYTOMETRY; HUMANS; IMMUNOHISTOCHEMISTRY; LEUKEMIA, MYELOID; MALE; MIDDLE AGED; NEOPLASM PROTEINS; P-GLYCOPROTEIN; SURVIVAL ANALYSIS; TREATMENT OUTCOME; VAULT RIBONUCLEOPROTEIN PARTICLES;

EID: 0033974917     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.2000.01793.x     Document Type: Article

References (33)

1. Beck, W.T., Grogan, T.M., Willman, C.L., Cordon-Cardo, C., Parham. D.M., Kuttesch, J.E, Andreeff, M., Bates, S.E., Berard, C.W., Boyett. J.M., Brophy, N.A., Broxterman, HJ., Chan. H.S.L., Dalton, W.S., Dietel. M., Fojo, A.T., Gascoyne, R.D., Head, D., Houghton, P.J., Srivastava, O.K., Lehnert, M., Leith. C.P., Paietta, E., Pavelic, Z.P., Rimsza, L, Roninson, I.E., Stkic, B.I., Twentyman, P.R., Warnke, R., Weinstein, R. (1996) Methods to detect P-glycoprotein-associated multidrug resistance in patients' tumours: Consensus recommendations. Cancer Research, 56, 3010-3022.
2. Borg. A.G., Burgess. R., Green, L.M., Scheper, R.J. & Liu Yin, J.A. (1998) Overexpression of lung-resistance protein and increased P-glycoprotein function in acute myeloid leukaemia cells predict a poor response to chemotherapy and reduced patient survival. British Journal of Haematologij. 10, 1083-1091.
3. Broxterman, H.J., Sonneveld, P., Pieters, R., Lankelma, J., Eekman, C.A., Leonen, A.H., Schoester, M., Ossenkoppele, G.J., Lowenberg, B., Pinedo, U.M. & Schuurhuis. G.J. (1999) Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia? Leukemia, 13, 258-265.
4. Campos, L., Guyotat, D., Jaffar, C., Solary, E., Archimbaud, E. & Treille, D. (1992) Correlation of MDR1/P-170 expression with daunorubicin uptake and sensitivity of leukemic progenitors in acute myeloid leukemia. European Journal of llacmatology, 48, 254-258.
5. Del Poeta. G., Stasi, R., Aronica, G., Venditti, A., Cox, M.C., Bruno, A., Buccisano, P., Masi, M., Tribalto, M., Amadori, S. & Papa. G. (1996) Clinical relevance of p-glycoprotein expression in de novo acute myeloid leukemia. Blood, 87, 1997-2004.
6. den Boer, M.L., Pieters, R., Kazemier. K.M., Rottier. M.M., Zwaan, C.M., Kaspers, G.J., Janka-Schaub, G., Henze, G., Creutzig, U., Scheper, R.J. & Veerman. A.J. (1998) Relationship between major vault protein/lung resistance protein, multidrug resistance-associated protein, P-glycoprotein expression, and drug resistance in childhood leukemia. Blood, 91, 2092-2098.
7. Filipitis, M., Pohl, G., Stranzl, T., Suchomel, R.W., Scheper, RJ., Jager, U, Geissler, K., Lechner, K. & Pirker, R. (1998) Expression of the lung resistance protein predicts poor outcome in the de novo acute myeloid leukemia. Blood, 91, 1508-1513.
8. Guerci, A., Merlin, J.L., Missoum, N., Feldmann, L., Marchai, S., Witz, F., Rose, C. & Guerci, O. (1995) Predictive value for treatment outcome in acute myeloid leukemia of cellular daunorubicin accumulation and P-glycoprotein expression simultaneously determined by flow cytometry. Blood, 85, 2147-2153.
9. Hart, S.M., Ganeshaguru, K., Scheper, R.J., Prentice, H.G., Hoffbrand, A.V. & Mehta, A.B. (1997) Expression of the human major vault protein LRP in acute myeloid leukaemia. Experimental Haematologij, 25, 1227-1232.
10. Hedley, D.W., Xiu-Yan Xie, S., Minden, M.D., Choi, C.H., Chen. H. & Ling, V. (1997) A novel energy dependent mechanism reducing daunorubicin accumulation in acute myeloid leukemia. Leukemia, 11,48-53.
11. Keizer, H.G., Schuurhuis, G.J., Broxterman, H.J., Lankelma, J., Schoonen, W.G.E.J., van Rijn, J., Pinedo, H.M. & Joenje, H. (1989) Correlation of Multidrug Resistance with decreased drug accumulation, altered subcellulardrug distribution, and increased P-glycoprotein expression in cultured SW-1573 human lung tumour cells. Cancer Research. 49, 2988-2993.
12. Kessel, D., Wilberding, C., Karanes, C. & Ratanatharathorn, V. (1984) Daunorubicin accumulation by human myeloblasts varying in anthracycline resistance. Cancer Letters, 24, 305-309.
13. Kokenberg, E., Sonneveld, P., Sio, W, Hagenbeek. A. & Lowenberg, B. (1988) Cellular pharmacokinetics ofdaunorubicin: relationships with the response to treatment in patients with acute myeloid leukemia. Journal of Clinical Oncology, 6, 802-812.
14. Krishnamachary, N. & Center, M.S. (1993) The MRP gene associated with a non-P-glycoprotein multidrug resistance encodes a 190-kDa membrane bound glycoprotein. Cancer Researdi, 53, 3658-3661.
15. Lamy, T., Drenou, B., Grulois. I., Fardel, O., Jacqueline, C., Goasguen, J., Dauriac, C., Amiot. L., Bernard, M., Fauchet, R. & Le Prise, P.Y. (1995) Multi-drug resistance (MDR) in leukemia determined by rhodamine 123 efflux assay. Leukemia, 9, 15-1555.
16. Lautier, D., Bailly, J.D., Demur, C., Herbert, J.M., Bousquet, C. & Laurent, G. (1997) Altered intracellular distribution of daunorubicin in immature acute myeloid leukemia cells. International Journal of Cancer, 10, 292-299.
17. Legrand, O., Simonin, G., Perrot, J.Y., Zittoun, R., Marie. J.P. (1998a) Pgp and MRP activities using calcein-AM are prognostic factors in adult acute myeloid leukemia patients. Blood, 91, 4480-4488.
18. Legrand, O., Simonin, R., Zittoun, R. & Marie, J-P. (1998b) Lung resistance protein (LRP) gene expression in adult acute myeloid leukaemia: a critical evaluation by three techniques. Leukemia, 12, 13-1374.
19. Legrand, O., Zittoun, R. & Marie, J-P. (1999) Role of MRP1 in multidrug resistance in acute myeloid leukemia. Leukemia, 13, 578-584.
20. Leith. C.P., Chen, I.M., Kopecky, K.J., Appelbaum, F.R., Head, F.R., Godwin, J.E., Weick, J.K. & William, C.L. (1995) Correlation of multidrug resistance (MDR1) protein expression with functional dye/drug efflux in acute myeloid leukemia by multiparameter flow cytometry: Identification of discordant MDR-/Efflux+ and AroRl+/Efflux- cases. Blood, 6, 2329-2342.
21. Leith, C.P., Kopecky, K.J., Chen, I.M., Eijdems, L., Slovak, M.L., McConnell, T.S., Head, D.R., Weick, J., Grever, M.R., Appelbaum, F.R., Willman, C.L. (1999) Frequency and clinical significance of the expression of the multidrug resistance proteins MDR1/P-glycoprotein, MRP1, and LRP in acute myeloid leukemia. A Southwest Oncology Group Study. Blood, 94, 1086-1099.
22. List. A.F., Spier, C.S., Grogan, T.M., Johnson, C., Roe, D.J., Greer, J.P., Wolff, S.N., Broxterman, HJ., Scheffer, G.L., Scheper, R.J. & Dalton, W.S. (1996) Overexpression of the major vault transporter protein lung-resistance protein predicts treatment outcome in acute myeloid leukemia. Blood, 87, 2464-2469.
23. Michieli, M., Damiani, D., Ermacora, A., Raspadori, D., Michelutti, A., Grimaz, S., Fanin, R., Russo, D., Lauria, F., Masolini, P. & Baccarani, M. (1996) P-glycoprotein (PGP) and lung resistancerelated protein (LRP) expression and function in leukaemic blast cells. British Journal of Haematology, 96, 356-365.
24. Nooter, K., Burger, H. & Stoter, G. (1996) Multidrug resistance-associated protein (MRP) in haematological malignancies. Leukemia Lymphoma, 20, 381-387.
25. Pallis, M. & Russell, N.H. (1998) Functional multidrug resistance in acute myeloblastic leukaemia: a standardised flow cytometric assay for the intracellular daunorubicin accumulation. British Journal of Haematology, 10, 194-197.
26. Pallis, M., Turzanski, J., Harrison, G., Wheatley, S., Langabeer, A., Burnett, A.K. & Russell, N.H. (1999) Use of standardized Dow cytometric determinants of multidrug resistance to analyse response to remission induction chemotherapy in patients with acute myeloblastic leukaemia. British Journal of Haematology, 10, 307-312.
27. Pastan, L, Gottesman, M.M., Ueda, K., Lovelace, E., Rutherford, A.V. & Willingham, M.C. (1988) A retrovirus carrying an MDR1 cDNA confers multidrug resistance and polarised expression of P-glycoprotein in MDCK cells. Proceedings of the National Academy of Science USA, 85, 4486-4490.
28. Rarau. A., Pollard, H.B. & Rosario, L.M. (1989) Doxorubicin resistance in P388 leukemia - evidence for reduced drug influx. International Journal of Cancer, 44, 539-547.
29. Scheffer, G.L., Wijngaard, P.L.J., Flens, M.J., Izquierdo. M.A., Slovak, M.L., Pinedo, H.M., Meijer C.J.L.M., devers, H.C. & Scheper, R.J. (1995) The drug resistance-related protein LRP is the human major vault protein. Nature Medicine, 1, 578-582.
30. Sehested, M., Bindslev, N., Demant, E.J., Skovsgaard, T. & Jensen, P.B. (1989) Daunorubicin and vincristine binding to plasma membrane vesicles from daunorubicin-resistant and wild type Ehrlich ascites tumour cells. Biochemistry-Pharmacology. 38, 3017-3027.
31. Slapak, C.A., Mizunuma, N. & Kufe, D.E. (1994) Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human rayeloid leukemia cells. Blood, 84, 3113-3121.
32. Zaman, G.J.R., Flens, M.J., van Leusden. M.R., De Haas, M., Mulder. H.S., Lankelma, J., Pinedo, H.M., Scheper, R.J., Baas, F., Broxterman, H.J. & Borst, P. (1994) The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proceedings of the National Academy of Science USA, 91, 8822-8826.
33. Zhou, D.C., Ramond, S., Viguie, F., Faussat. A.M., Zittoun, R. & Marie J.P. (1996) Progressive resistance to homoharringtonine in human myeloleukemia K562 cells: relationship to sequential emergence of MRP and MDR1 gene overexpression and MDR1 gene translation. International Journal of Cancer, 65, 365-371.